No difference between TZDs and DPP-4 inhibitors or sulphonylureas added to metformin in type 2 diabetes

No difference between TZDs and DPP-4 inhibitors or sulphonylureas added to metformin in type 2 diabetes

Research question: In people with type 2 diabetes inadequately controlled with metformin, which additional oral therapy offers the greatest improvement in HbA1c? The reviewers just looked at glycaemic control in patients whose starting HbA1c was 7% or higher at 12 weeks or longer follow-up. The evidence: Eight randomised trials were found, which looked at various …

No difference between TZDs and DPP-4 inhibitors or sulphonylureas added to metformin in type 2 diabetes Read More »